Serum Institute of India (SII) on Thursday said it’s pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate within the…
Browsing: DGCI
Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2…